
Investments
20Portfolio Exits
4Partners & Customers
10About Asahi Kasei
Asahi Kasei provides solutions based in chemistry and materials science to a diverse range of markets including fibers, chemicals, consumer products, housing, construction, electronics, and health care. The company was founded in 1974 and is based in Tokyo, Japan.
Asahi Kasei Headquarter Location
1-105 Kanda Jinbocho, Chiyoda-ku
Tokyo, 101-8101,
Japan
+81-(0)3-3296-3000
Expert Collections containing Asahi Kasei
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Find Asahi Kasei in 1 Expert Collection, including Medical Devices.
Medical Devices
295 items
Companies that received PMA from the FDA since 2014. Companies tagged as #FDAPMA
Asahi Kasei Web Traffic
Asahi Kasei Rank
Latest Asahi Kasei News
May 10, 2022
Global Superdisintegrants Market Research Report to 2027... Search jobs 10-May-2022 Global Superdisintegrants Market Research Report to 2027 - Featuring Anshul Life Sciences, Asahi Kasei and Ashland Global Specialty Chemicals Among Others - ResearchAndMarkets.com Market Statistics: The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period. Competitive Strategic Window: The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period. FPNV Positioning Matrix: The FPNV Positioning Matrix evaluates and categorizes the vendors in the Superdisintegrants Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape. Market Share Analysis: The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits. The report provides insights on the following pointers: 1. Market Penetration: Provides comprehensive information on the market offered by the key players 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments The report answers questions such as: 1. What is the market size and forecast of the Global Superdisintegrants Market? 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Superdisintegrants Market during the forecast period? 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Superdisintegrants Market? 4. What is the competitive strategic window for opportunities in the Global Superdisintegrants Market? 5. What are the technology trends and regulatory frameworks in the Global Superdisintegrants Market? 6. What is the market share of the leading vendors in the Global Superdisintegrants Market? 7. What modes and strategic moves are considered suitable for entering the Global Superdisintegrants Market? Market Dynamics
Asahi Kasei Investments
20 Investments
Asahi Kasei has made 20 investments. Their latest investment was in Rege Nephro as part of their Series A - II on January 1, 2022.
Asahi Kasei Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
---|---|---|---|---|---|---|
1/31/2022 | Series A - II | Rege Nephro | $12.06M | Yes | 3 | |
10/19/2021 | Series A | HistoWiz | $32M | Yes | Jon Oringer, venBIO, and Vivo Capital | 11 |
5/19/2021 | Series C | Super Home | $50M | Yes | 3 | |
12/1/2020 | Corporate Minority | |||||
9/9/2020 | Series C |
Date | 1/31/2022 | 10/19/2021 | 5/19/2021 | 12/1/2020 | 9/9/2020 |
---|---|---|---|---|---|
Round | Series A - II | Series A | Series C | Corporate Minority | Series C |
Company | Rege Nephro | HistoWiz | Super Home | ||
Amount | $12.06M | $32M | $50M | ||
New? | Yes | Yes | Yes | ||
Co-Investors | Jon Oringer, venBIO, and Vivo Capital | ||||
Sources | 3 | 11 | 3 |
Asahi Kasei Portfolio Exits
4 Portfolio Exits
Asahi Kasei has 4 portfolio exits. Their latest portfolio exit was Rapid Micro Biosystems on July 16, 2021.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
---|---|---|---|---|---|
7/16/2021 | IPO | 4 | |||
Date | 7/16/2021 | |||
---|---|---|---|---|
Exit | IPO | |||
Companies | ||||
Valuation | ||||
Acquirer | ||||
Sources | 4 |
Asahi Kasei Acquisitions
11 Acquisitions
Asahi Kasei acquired 11 companies. Their latest acquisition was Bionova Scientific on April 18, 2022.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
---|---|---|---|---|---|---|
4/18/2022 | Private Equity | $13.3M | Acquired | 3 | ||
12/15/2021 | Acquired | 3 | ||||
3/4/2020 | Acq - P2P | 3 | ||||
12/4/2018 | ||||||
7/19/2018 |
Date | 4/18/2022 | 12/15/2021 | 3/4/2020 | 12/4/2018 | 7/19/2018 |
---|---|---|---|---|---|
Investment Stage | Private Equity | ||||
Companies | |||||
Valuation | |||||
Total Funding | $13.3M | ||||
Note | Acquired | Acquired | Acq - P2P | ||
Sources | 3 | 3 | 3 |
Asahi Kasei Partners & Customers
10 Partners and customers
Asahi Kasei has 10 strategic partners and customers. Asahi Kasei recently partnered with Genomatica on March 3, 2022.
Date | Type | Business Partner | Country | News Snippet | Sources |
---|---|---|---|---|---|
3/15/2022 | Vendor | United States | NEW YORK & TOKYO -- -- Asahi Kasei , a diversified Japanese multinational company , has formed a strategic partnership with Genomatica , Inc. , regarding hexamethylenediamine based on biomass-derived raw material . | 6 | |
3/8/2022 | Licensor | United States | ExThera Medical, Asahi Kasei Medical Forge Distribution Pact `` ExThera Medical Corporation 's partnership with Asahi Kasei Medical is an important milestone in our collaborative ongoing fight against life threatening pathogens . | 1 | |
12/21/2021 | Licensor | United States | `` ExThera Medical Corporation 's partnership with Asahi Kasei Medical is an important milestone in our collaborative ongoing fight against life threatening pathogens . | 2 | |
11/24/2021 | Vendor | ||||
1/28/2021 | Licensee |
Date | 3/15/2022 | 3/8/2022 | 12/21/2021 | 11/24/2021 | 1/28/2021 |
---|---|---|---|---|---|
Type | Vendor | Licensor | Licensor | Vendor | Licensee |
Business Partner | |||||
Country | United States | United States | United States | ||
News Snippet | NEW YORK & TOKYO -- -- Asahi Kasei , a diversified Japanese multinational company , has formed a strategic partnership with Genomatica , Inc. , regarding hexamethylenediamine based on biomass-derived raw material . | ExThera Medical, Asahi Kasei Medical Forge Distribution Pact `` ExThera Medical Corporation 's partnership with Asahi Kasei Medical is an important milestone in our collaborative ongoing fight against life threatening pathogens . | `` ExThera Medical Corporation 's partnership with Asahi Kasei Medical is an important milestone in our collaborative ongoing fight against life threatening pathogens . | ||
Sources | 6 | 1 | 2 |
You May Also Like
UBE manufactures and develops chemicals, plastics, pharmaceuticals, machinery and metal products, cement, and construction materials. It is based in Gurgaon, India.
Kuraray provides chemical manufacturing production and sale of functional resins, chemical products, man-made leathers, synthetic fibers and textiles, optics-related products, and medical products. It is based in Tokyo, Japan.
Mitsui Chemicals (TYO: 4183) manufactures petrochemicals, basic chemicals, polyurethanes, functional polymeric materials, functional chemicals, and films & sheets.
Shin-Etsu Chemical (TYO: 4063) is a chemicals company that offers products including silicones, cellulose derivatives, fluorinated products/silica products, and more.
Sumitomo Chemical has developed a number of plant protection chemicals, ranging from conventional insecticides, fungicides and herbicides to new types of products, including plant growth regulators.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.